Specialty chemical manufacturing company Tatva Chintan Pharma Chem said that Mahesh Tanna ... requirements for expansion of the company's Dahej manufacturing facility; up-gradation of a research ...

Tatva Chintan Pharma Chem Limited was formerly incorporated as ... through two world class manufacturing facilities located at Dahej and Ankleshwar in Gujarat both of which are strategically ...

Proceeds from the fresh issue would be used towards funding capital expenditure requirements for expansion of the company's Dahej manufacturing facility; up-gradation of an R&D facility in ...

Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve and take on record the ...

Specialty chemical manufacturing company Tatva Chintan Pharma Chem on Tuesday fixed a ... requirements for expansion of the company's Dahej manufacturing facility; upgradation of research and ...

Tatva Chintan Pharma Chem Q1 Results Live : Tatva Chintan Pharma Chem declared their Q1 results on 24 Jul, 2024. The topline decreased by 7.78% & the profit decreased by 45.19% YoY. As compared to ...

KR Choksey recommended reduce rating on Tatva Chintan Pharma Chem with a target price of Rs 761 in its research report dated January 30 2025. KR Choksey recommended reduce rating on Tatva Chintan ...

Tatva Chintan Pharma Chem Limited 955.95 -1.97% Summary News Research Chart Community Statistics Historical Data Profile Financials Analysis Options Holders Sustainability NSE - Delayed Quote ...

Tatva Chintan Pharma Chem, operating in the Chemicals - Speciality sector and classified as a Smallcap on the BSE, currently has its share price at ₹915.75. The stock has experienced ...

About Tatva Chintan Pharma Chem Ltd. Tatva Chintan Pharma Chem Ltd. is a chemicals manufacturing company. The firm is engaged in the manufacture of portfolio, which includes structure directing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...